Clinical Trial Update: Pharmacokinetics (PK) and Safety Study of XARTEMIS® XR in Postsurgical Adolescent Subjects With Moderate to Severe Acute Pain [Phase 4]

View source ↗

Summary

Phase 4 PK and safety study of XARTEMIS XR in post-surgical adolescents with moderate to severe acute pain terminated; results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pain

Drugs mentioned

• XARTEMIS XR

Snippet

Sponsor: Mallinckrodt | Conditions: Acute Pain | Phase 4 | Status: TERMINATED | Results posted: 2020-01-22